Literature DB >> 18003807

Granulomatous amoebic encephalitis caused by Acanthamoeba amoebae of genotype T2 in a human immunodeficiency virus-negative patient.

Julia Walochnik1, Alexander Aichelburg, Ojan Assadian, Andrea Steuer, Govinda Visvesvara, Norbert Vetter, Horst Aspöck.   

Abstract

Acanthamoeba amoebae of genotype T2 were identified as the causative agent of Acanthamoeba skin lesions and granulomatous amoebic encephalitis (GAE) in a human immunodeficiency virus-negative patient with underlying tuberculosis. To our knowledge this, is the first case of GAE involving genotype T2.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18003807      PMCID： PMC2224275          DOI： 10.1128/JCM.01177-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials.

Authors:  T Singhal; A Bajpai; V Kalra; S K Kabra; J C Samantaray; G Satpathy; A K Gupta
Journal:  Pediatr Infect Dis J       Date:  2001-06       Impact factor: 2.129

2.  Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge.

Authors:  J M Schroeder; G C Booton; J Hay; I A Niszl; D V Seal; M B Markus; P A Fuerst; T J Byers
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Acanthamoeba genotype T4 from the UK and Iran and isolation of the T2 genotype from clinical isolates.

Authors:  Amir Hossein Maghsood; James Sissons; Mostafa Rezaian; Debbie Nolder; David Warhurst; Naveed Ahmed Khan
Journal:  J Med Microbiol       Date:  2005-08       Impact factor: 2.472

4.  Inability to make a premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis.

Authors:  Karen C Bloch; Frederick L Schuster
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Survival of environmental mycobacteria in Acanthamoeba polyphaga.

Authors:  Toïdi Adékambi; Skandar Ben Salah; Mohamed Khlif; Didier Raoult; Michel Drancourt
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

6.  Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity.

Authors:  J Walochnik; A Obwaller; E M Haller-Schober; H Aspöck
Journal:  Parasitol Res       Date:  2001-08       Impact factor: 2.289

7.  Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.

Authors:  Julia Walochnik; Michael Duchêne; Karin Seifert; Andreas Obwaller; Thomas Hottkowitz; Gerhard Wiedermann; Hansjörg Eibl; Horst Aspöck
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 8.  Disseminated acanthamebiasis in a renal transplant recipient with osteomyelitis and cutaneous lesions: case report and literature review.

Authors:  Jordan P Steinberg; Rene L Galindo; Edward S Kraus; Khalil G Ghanem
Journal:  Clin Infect Dis       Date:  2002-08-02       Impact factor: 9.079

Review 9.  Cerebrospinal acanthamebic granulomas. Case report.

Authors:  Vernon Velho; Gopal Krishan Sharma; Deepak Amrut Palande
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

10.  Acanthamoeba encephalitis in patient with systemic lupus, India.

Authors:  Charudatt G Shirwadkar; Rohini Samant; Milind Sankhe; Ramesh Deshpande; Shigeo Yagi; Frederick L Schuster; Rama Sriram; Govinda S Visvesvara
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883
View more
  28 in total

1.  Phylogenetic evidence for a new genotype of Acanthamoeba (Amoebozoa, Acanthamoebida).

Authors:  Daniele Corsaro; Danielle Venditti
Journal:  Parasitol Res       Date:  2010-04-22       Impact factor: 2.289

2.  Acanthamoeba strains show reduced temperature tolerance after long-term axenic culture.

Authors:  Wilawan Pumidonming; Martina Koehsler; Julia Walochnik
Journal:  Parasitol Res       Date:  2009-12-15       Impact factor: 2.289

3.  Molecular detection and comparison of Acanthamoeba genotypes in different functions of watersheds in Taiwan.

Authors:  Po-Min Kao; Bing-Mu Hsu; Nai-Hsiung Chen; Kuan-Hao Huang; Chin-Chun Huang; Dar-Der Ji; Jung-Sheng Chen; Wei-Chen Lin; Shih-Wei Huang; Yi-Chou Chiu
Journal:  Environ Monit Assess       Date:  2011-07-30       Impact factor: 2.513

4.  Novel Acanthamoeba 18S rRNA gene sequence type from an environmental isolate.

Authors:  A Magnet; N Henriques-Gil; A L Galván-Diaz; F Izquiedo; S Fenoy; C del Aguila
Journal:  Parasitol Res       Date:  2014-05-25       Impact factor: 2.289

5.  Seasonal distribution of potentially pathogenic Acanthamoeba species from drinking water reservoirs in Taiwan.

Authors:  Po-Min Kao; Bing-Mu Hsu; Tsui-Kang Hsu; Jorn-Hon Liu; Hsiang-Yu Chang; Wen-Tsai Ji; Kai-Jiun Tzeng; Shih-Wei Huang; Yu-Li Huang
Journal:  Environ Sci Pollut Res Int       Date:  2014-09-30       Impact factor: 4.223

6.  Acanthamoeba spp. and Balamuthia mandrillaris leading to fatal granulomatous amebic encephalitis.

Authors:  Daniel C Lee; Steven E Fiester; Lee A Madeline; James W Fulcher; Michael E Ward; Christine Marie-Gilligan Schammel; Ryan K Hakimi
Journal:  Forensic Sci Med Pathol       Date:  2019-11-26       Impact factor: 2.007

7.  Acanthamoeba and Dictyostelium Use Different Foraging Strategies.

Authors:  Nick A Kuburich; Nirakar Adhikari; Jeffrey A Hadwiger
Journal:  Protist       Date:  2016-09-06

8.  In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.

Authors:  Anjan Debnath; Josefino B Tunac; Angélica Silva-Olivares; Silvia Galindo-Gómez; Mineko Shibayama; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

9.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02

10.  Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine.

Authors:  Alexander C Aichelburg; Julia Walochnik; Ojan Assadian; Helmut Prosch; Andrea Steuer; Gedeon Perneczky; Govinda S Visvesvara; Horst Aspöck; Norbert Vetter
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.